AdvertisementFDA Poised For Decision On Controversial Alzheimer's DrugJune 04, 2021Jon HamiltonfacebookEmailDr. William Burke reviews a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018. An experimental Alzheimer's drug from Biogen and Eisai is on the verge of a Food and Drug Administration decision. (AP)
